A significant knowledge gap exists concerning the geographical distribution of nontuberculous
mycobacteria (NTM) isolation worldwide. To provide a snapshot of NTM species …

Major epidemics, including some that qualify as pandemics, such as severe acute
respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), HIV, influenza A (H1N1)pdm/…

Background Antibiotic resistance is a major global health problem and pathogens such as
meticillin-resistant Staphylococcus aureus (MRSA) have become of particular concern in the …

Objectives To evaluate the access to comprehensive diagnostics and novel antituberculosis
medicines in European countries. Methods We investigated the access to genotypic and …

Rifapentine, a synthetic derivate of rifampicin which was developed in 1965, has interesting
pharmacological properties, including a long terminal half-life (13 h, compared to 2–3 h for …

Background and objective Enterobacteriaceae (EB) spp. family is known to include
potentially multidrug‐resistant (MDR) microorganisms, and remains as an important cause of …

Mycobacterium tuberculosis remains a major global health problem and is currently killing
1.5 million people every year. One of the most important steps in tuberculosis control is the …

Background Aspiration community-acquired pneumonia (ACAP) and community-acquired
pneumonia (CAP) in patients with aspiration risk factors (AspRFs) are infections associated …

Background Who should be tested for viruses in patients with community acquired pneumonia
(CAP), prevalence and risk factors for viral CAP are still debated. We evaluated the …

Drug-resistant tuberculosis (TB) is estimated to account for approximately 30% of the
annual deaths due to antimicrobial resistance (AMR)[1]. This is mainly due to the mortality of …